Binding of Gtf2i-β/δ transcription factors to the ARMS2 gene leads to increased circulating HTRA1 in AMD patients and in vitro

Autor: Mao Nakayama, Subhabrata Chakrabarti, Inderjeet Kaur, Margaret M DeAngelis, Taraprasad Das, Toru Noda, Megumi Yamamoto, Daisuke Iejima, Paul N. Baird, Akiko Suga, Robyn H. Guymer, Takeshi Iwata, Yang Pan

Publikováno v: The Journal of Biological Chemistry

The disease-initiating molecular events for age-related macular degeneration (AMD), a multifactorial retinal disease affecting many millions of elderly individuals worldwide, are still unknown. Of the over 30 risk and protective loci so far associate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47857712d23c3c53fbf629db43532576
https://doi.org/10.1016/j.jbc.2021.100456

A Comprehensive CNN Model for Age-Related Macular Degeneration Classification Using OCT: Integrating Inception Modules, SE Blocks, and ConvMixer.

Autor: Yusufoğlu, Elif¹ (AUTHOR) elif.eraslan@yahoo.com, Fırat, Hüseyin² (AUTHOR) huseyin.firat@dicle.edu.tr, Üzen, Hüseyin³ (AUTHOR) huzen@bingol.edu.tr, Özçelik, Salih Taha Alperen⁴ (AUTHOR) sozcelik@bingol.edu.tr, Çiçek, İpek Balıkçı⁵ (AUTHOR) ipek.balikci@inonu.edu.tr, Şengür, Abdulkadir⁶ (AUTHOR) ksengur@firat.edu.tr, Atila, Orhan⁶ (AUTHOR) oatila@firat.edu.tr, Guldemir, Numan Halit⁷ (AUTHOR) nguldemir01@qub.ac.uk

Publikováno v: Diagnostics (2075-4418). Dec2024, Vol. 14 Issue 24, p2836. 26p.

Expert Panel Consensus for Optimizing Outcomes in Neovascular Age-Related Macular Degeneration in the Context of Suboptimal Response to a Biosimilar: The Role of Aflibercept.

Autor: Narendran, Nirodhini (AUTHOR), Bailey, Clare (AUTHOR), Downey, Louise (AUTHOR), Gale, Richard (AUTHOR), Kotagiri, Ajay (AUTHOR), Pearce, Ian (AUTHOR), Rennie, Christina A (AUTHOR), Sivaprasad, Sobha (AUTHOR), Talks, James (AUTHOR), Morgan-Warren, Peter (AUTHOR), Napier, Jackie (AUTHOR), O'Neil, Carolyn (AUTHOR), Seeborne, Timothy (AUTHOR)

Publikováno v: Clinical Ophthalmology. Nov2024, Vol. 18, p3133-3142. 10p.

Cost-effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration and its Subtypes from the Societal and Patient Perspectives in Japan.

Autor: Yanagi, Yasuo¹ (AUTHOR) yanagi.yas.wu@yokohama-cu.ac.jp, Takahashi, Kanji² (AUTHOR), Iida, Tomohiro³ (AUTHOR), Gomi, Fumi⁴ (AUTHOR), Onishi, Hiroshi⁵ (AUTHOR), Morii, Junko⁶ (AUTHOR), Sakamoto, Taiji⁷ (AUTHOR)

Publikováno v: Ophthalmology & Therapy. Oct2024, Vol. 13 Issue 10, p2629-2644. 16p.

Safety and Efficacy of Multiple Escalating Doses of RC28-E for Neovascular Age-Related Macular Degeneration: A Phase 1b Trial.

Autor: Lu, Yingyi¹ (AUTHOR), Yu, Xiaobing¹ (AUTHOR), Chen, Youxin² (AUTHOR), Wu, Chan² (AUTHOR), Jiang, Qin³ (AUTHOR), Ha, Shaoping⁴ (AUTHOR), Zhu, Dan⁵ (AUTHOR), Bi, Yanlong⁶ (AUTHOR), Liu, Xiaoling⁷ (AUTHOR), Zhang, Han⁸ (AUTHOR), Li, Zhuo⁹ (AUTHOR), Wang, Wenxiang¹⁰ (AUTHOR), Li, Lin¹⁰ (AUTHOR), Chen, He¹⁰ (AUTHOR), Zhang, Yifan¹⁰ (AUTHOR), Dai, Hong¹ (AUTHOR) dai-hong@x263.net, Fang, Jianmin¹¹ (AUTHOR) jfang@tongji.edu.cn

Publikováno v: Ophthalmology & Therapy. Sep2024, Vol. 13 Issue 9, p2405-2415. 11p.